Comment on

• Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD.

  Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Rosen HJ, et al. Neurology. 2002 Jun 11;58(11):1608-15. doi: 10.1212/wnl.58.11.1608. Neurology. 2002. PMID: 12058087
• The prevalence of frontotemporal dementia.

  Ratnavalli E, Brayne C, Dawson K, Hodges JR. Ratnavalli E, et al. Neurology. 2002 Jun 11;58(11):1615-21. doi: 10.1212/wnl.58.11.1615. Neurology. 2002. PMID: 12058088
• Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

  Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A. Riemenschneider M, et al. Neurology. 2002 Jun 11;58(11):1622-8. doi: 10.1212/wnl.58.11.1622. Neurology. 2002. PMID: 12058089